egenerative medicine is the branch of medicine which uses
therapeutically induced or laboratory-grown human tissue to treat
injured or diseased human cells, tissues, or organs. This branch of
medicine focuses on repairing, replacing, or regenerating the damaged
cells of the body and thus represents a paradigm shift in healthcare
treatment. The two main technologies used in regenerative medicine are
tissue engineering and stem cell technology. Analysts forecast the Regenerative Medicine market in the US will grow at a CAGR of 19.88 percent over the period 2013-2018.
The
Regenerative Medicine market in the US can be divided into 11 segments:
Orthopedic Tendon and Ligament, Chronic and Acute Wounds, Cardiology,
Plastic and Reconstructive Surgery, Osteoarthritis, Trauma, General
Surgery, Hernia Repair, Burns, Urology, and Urogynecology.
Regenerative
Medicine Market in the US 2014-2018, has been prepared based on an
in-depth market analysis with inputs from industry experts. It focuses
on the Regenerative Medicine market in the US landscape and its growth
prospects in the coming years. The report also includes a discussion of
the key vendors operating in this market.
Key Country
US
Key Vendors
- IBM Corp.
- Oracle Corp.
- SAP AG
- SAS Institute Inc.
Browse All Reports on Biotechnology Market
